tiprankstipranks
Trending News
More News >
Aziyo Biologics (ELUT)
NASDAQ:ELUT
US Market

Aziyo Biologics (ELUT) Income Statement

Compare
66 Followers

Aziyo Biologics Income Statement

Last quarter (Q4 2024), Aziyo Biologics's total revenue was $5.47M, a decrease of -6.93% from the same quarter last year. In Q4, Aziyo Biologics's net income was $-9.06M. See Aziyo Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 24.38M$ 24.75M$ 23.85M$ 47.39M$ 42.68M
Gross Profit
$ 10.71M$ 11.05M$ 11.64M$ 19.02M$ 20.56M
Operating Expenses
$ 46.36M$ 41.58M$ 41.63M$ 42.05M$ 34.16M
Depreciation and Amortization
$ 3.45M$ 3.51M$ 3.57M$ 3.73M$ 3.86M
EBITDA
$ -45.89M$ -31.92M$ -27.46M$ -15.72M$ -12.30M
Operating Income
$ -35.65M$ -30.53M$ -29.99M$ -23.03M$ -13.60M
Other Income/Expenses
$ -18.47M$ -10.70M$ -6.16M$ -1.75M$ -8.20M
Pretax Income
$ -54.12M$ -41.22M$ -36.15M$ -24.78M$ -21.80M
Net Income
$ -53.95M$ -37.66M$ -32.90M$ -24.83M$ -21.82M
Per Share Metrics
Basic EPS
$ -1.86$ -2.07$ -2.38$ -2.38$ -2.13
Diluted EPS
$ -1.86$ -2.07$ -2.38$ -2.38$ -2.13
Weighted Average Shares Outstanding
29.07M 18.16M 13.83M 10.44M 10.23M
Weighted Average Shares Outstanding (Diluted)
29.07M 18.16M 13.83M 10.44M 10.23M
Currency in USD

Aziyo Biologics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis